Biotricity Price to Sales Ratio 2015-2025 | BTCY
Historical PS ratio values for Biotricity (BTCY) over the last 10 years. The current P/S ratio for Biotricity as of June 19, 2026 is .
| Biotricity P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-06-17 | 0.12 | 0.20 | |
| 2025-12-31 | 0.30 | $0.61 | 0.49 |
| 2025-09-30 | 0.53 | $0.61 | 0.86 |
| 2025-06-30 | 0.37 | $0.61 | 0.60 |
| 2025-03-31 | 0.34 | $0.69 | 0.49 |
| 2024-12-31 | 0.29 | $0.87 | 0.33 |
| 2024-09-30 | 0.24 | $1.06 | 0.22 |
| 2024-06-30 | 0.90 | $1.24 | 0.73 |
| 2024-03-31 | 1.48 | $1.36 | 1.09 |
| 2023-12-31 | 1.15 | $1.32 | 0.87 |
| 2023-09-30 | 2.14 | $1.27 | 1.68 |
| 2023-06-30 | 3.83 | $1.22 | 3.13 |
| 2023-03-31 | 2.79 | $0.92 | 3.05 |
| 2022-12-31 | 2.69 | $0.88 | 3.05 |
| 2022-09-30 | 4.80 | $0.83 | 5.75 |
| 2022-06-30 | 10.62 | $0.81 | 13.09 |
| 2022-03-31 | 13.62 | $1.04 | 13.07 |
| 2021-12-31 | 23.88 | $0.95 | 25.18 |
| 2021-09-30 | 17.64 | $0.87 | 20.18 |
| 2021-06-30 | 18.87 | $0.74 | 25.44 |
| 2021-03-31 | 14.37 | $0.54 | 26.38 |
| 2020-12-31 | 4.43 | $0.42 | 10.66 |
| 2020-09-30 | 6.66 | $0.32 | 20.96 |
| 2020-06-30 | 8.20 | $0.26 | 32.07 |
| 2020-03-31 | 5.84 | $0.24 | 24.61 |
| 2019-12-31 | 3.78 | $0.21 | 18.10 |
| 2019-09-30 | 3.48 | $0.17 | 20.92 |
| 2019-06-30 | 3.96 | $0.12 | 32.02 |
| 2019-03-31 | 5.46 | $0.07 | 76.20 |
| 2018-12-31 | 2.88 | $0.04 | 72.55 |
| 2018-09-30 | 11.46 | $0.02 | 607.00 |
| 2018-06-30 | 18.96 | $0.00 | 0.00 |
| 2018-03-31 | 22.14 | 0 | 0.00 |
| 2017-12-31 | 45.54 | 0 | 0.00 |
| 2017-09-30 | 13.08 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.014B |
| Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |